Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
70.50
-0.20 (-0.28%)
Aug 6, 2026, 9:14 AM CET

WSE:CTX Cash Flow Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-42.63-42-38.43-70.53-35.89-32.57
Depreciation & Amortization
4.044.375.065.447.097.36
Stock-Based Compensation
0.5411.994.588.019.5
Other Adjustments
1.28-1.46-0.44-2.78-2.690.45
Change in Receivables
1.4236.57-25.88-3.071.53-9.88
Changes in Accounts Payable
-5.09-4.772.12-0.273.36-8.79
Changes in Other Operating Activities
-4.41-2.92-4.5914.42-4.365.47
Operating Cash Flow
-72.98-37.32-31.88-52.2-22.95-28.47
Operating Cash Flow Growth
------
Capital Expenditures
-0.19-0.21-0.42-3.01-0.89-5.11
Purchases of Investments
-33.53-63.69-5.93-50.45-53.54-
Proceeds from Sale of Investments
-42.75670.1233.87-
Other Investing Activities
1.611.280.633.272.93-
Investing Cash Flow
30.56-19.870.2719.93-17.63-5.11
Long-Term Debt Repaid
------0.21
Net Long-Term Debt Issued (Repaid)
------0.21
Issuance of Common Stock
32.932.9040.010148.24
Net Common Stock Issued (Repurchased)
32.932.9040.010148.24
Other Financing Activities
-4.76-4.25-4.85-3.07-6.33-7.16
Financing Cash Flow
28.1528.65-4.8436.94-6.33140.88
Net Cash Flow
-14.28-28.54-36.454.67-46.91107.29
Free Cash Flow
-73.17-37.53-32.3-55.21-23.84-33.59
Free Cash Flow Growth
------
FCF Margin
-3071.66%-805.36%-204.12%-418.22%-260.32%-842.60%
Free Cash Flow Per Share
-13.23-6.80-6.93-11.58-5.47-7.71
Levered Free Cash Flow
-48.3-45.52-36.27-54-30.69-33.86
Unlevered Free Cash Flow
-39.55-47.09-36.81-56.49-33.16-32.79